Research Articles | Page 3 | Aplastic Anemia and MDS International Foundation (AAMDSIF) Return to top.

Research Articles

Compiled for your convenience are articles on bone marrow failure research and treatment from the world’s major journals on hematology / oncology.

Article Title Original Publication Date Journal Bone Marrow Disease
Standardization of Bone Marrow Reporting for Myelodysplastic Syndromes/Neoplasms on Behalf of the International Consortium for Myelodysplastic Syndromes/Neoplasms Mar 2025 Archives of Pathology & Laboratory Medicine Myelodysplastic Syndromes (MDS)
STAT signaling in the pathogenesis and therapy of acute myeloid leukemia and myelodysplastic syndromes Mar 2025 Neoplasia Myelodysplastic Syndromes (MDS)
Outpatient subcutaneous alemtuzumab is feasible and safe for aplastic anemia and is associated with high response rates Feb 2025 Blood Advances Aplastic Anemia
Thrombosis at Unusual Sites: Focus on Myeloproliferative Neoplasms and Paroxysmal Nocturnal Hemoglobinuria Feb 2025 Hamostaseologie Myeloproliferative Neoplasms (MPN), Paroxysmal Nocturnal Hemoglobinuria (PNH)
Survival and quality of life in patients with lower risk myelodysplastic syndromes exposed to erythropoiesis-stimulating agents: an observational cohort study Feb 2025 Lancet Haematology Myelodysplastic Syndromes (MDS)
Genome sequencing in the management of myelodysplastic syndromes and related disorders Feb 2025 Haematologica Myelodysplastic Syndromes (MDS)
Diagnosis of myelodysplastic syndromes: the classic and the novel Feb 2025 Haematologica Myelodysplastic Syndromes (MDS)
Treatment of high-risk myelodysplastic syndromes Feb 2025 Haematologica Myelodysplastic Syndromes (MDS)
Treatment of lower-risk myelodysplastic syndromes Feb 2025 Haematologica Myelodysplastic Syndromes (MDS)
Current landscape of paroxysmal nocturnal hemoglobinuria in the era of complement inhibitors and regulators Dec 2024 Therapeutic Advances in Hematology Paroxysmal Nocturnal Hemoglobinuria (PNH)